Morgan Stanley’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$134M Buy
2,428,689
+1,385,804
+133% +$76.2M 0.01% 1120
2025
Q1
$73.7M Sell
1,042,885
-297,547
-22% -$21M 0.01% 1481
2024
Q4
$88.1M Buy
1,340,432
+470,208
+54% +$30.9M 0.01% 1354
2024
Q3
$61.2M Sell
870,224
-326,539
-27% -$23M ﹤0.01% 1646
2024
Q2
$98.5M Buy
1,196,763
+186,514
+18% +$15.4M 0.01% 1188
2024
Q1
$88.2M Sell
1,010,249
-870,495
-46% -$76M 0.01% 1285
2023
Q4
$181M Buy
1,880,744
+1,119,237
+147% +$108M 0.01% 1224
2023
Q3
$67.4M Sell
761,507
-124,714
-14% -$11M 0.01% 1325
2023
Q2
$76.8M Sell
886,221
-2,262
-0.3% -$196K 0.01% 1255
2023
Q1
$86.4M Sell
888,483
-206,873
-19% -$20.1M 0.01% 1150
2022
Q4
$113M Buy
1,095,356
+276,841
+34% +$28.7M 0.01% 954
2022
Q3
$69.4M Sell
818,515
-225,802
-22% -$19.1M 0.01% 1104
2022
Q2
$86.5M Buy
1,044,317
+391,301
+60% +$32.4M 0.01% 1019
2022
Q1
$50.3M Buy
653,016
+222,564
+52% +$17.2M 0.01% 1305
2021
Q4
$38M Sell
430,452
-327,622
-43% -$28.9M ﹤0.01% 1547
2021
Q3
$58.6M Buy
758,074
+17,576
+2% +$1.36M 0.01% 1188
2021
Q2
$61.8M Sell
740,498
-40,727
-5% -$3.4M 0.01% 1163
2021
Q1
$59M Buy
781,225
+120,926
+18% +$9.13M 0.01% 1055
2020
Q4
$57.9M Buy
660,299
+139,166
+27% +$12.2M 0.01% 988
2020
Q3
$39.6M Sell
521,133
-51,593
-9% -$3.93M 0.01% 1034
2020
Q2
$70.6M Buy
572,726
+25,986
+5% +$3.21M 0.02% 688
2020
Q1
$46.2M Buy
546,740
+88,791
+19% +$7.5M 0.01% 775
2019
Q4
$38.7M Sell
457,949
-13,530
-3% -$1.14M 0.01% 1112
2019
Q3
$31.8M Sell
471,479
-85,137
-15% -$5.74M 0.01% 1138
2019
Q2
$47.7M Buy
556,616
+217,847
+64% +$18.7M 0.01% 876
2019
Q1
$30.1M Sell
338,769
-257,205
-43% -$22.8M 0.01% 1141
2018
Q4
$50.7M Buy
595,974
+150,165
+34% +$12.8M 0.02% 811
2018
Q3
$43.2M Sell
445,809
-141,367
-24% -$13.7M 0.01% 1045
2018
Q2
$55.3M Buy
587,176
+123,430
+27% +$11.6M 0.01% 858
2018
Q1
$37.6M Sell
463,746
-9,018
-2% -$731K 0.01% 1116
2017
Q4
$42.2M Buy
472,764
+49,096
+12% +$4.38M 0.01% 1069
2017
Q3
$39.4M Sell
423,668
-35,600
-8% -$3.31M 0.01% 1054
2017
Q2
$41.7M Buy
459,268
+52,008
+13% +$4.72M 0.01% 1013
2017
Q1
$35.8M Buy
407,260
+36,286
+10% +$3.19M 0.01% 1121
2016
Q4
$30.7M Sell
370,974
-31,668
-8% -$2.62M 0.01% 1184
2016
Q3
$37.3M Buy
402,642
+84,868
+27% +$7.85M 0.01% 1030
2016
Q2
$24.7M Sell
317,774
-49,665
-14% -$3.86M 0.01% 1258
2016
Q1
$30.3M Buy
367,439
+127,720
+53% +$10.5M 0.01% 1049
2015
Q4
$25.1M Sell
239,719
-124,174
-34% -$13M 0.01% 1239
2015
Q3
$38.3M Buy
363,893
+83,877
+30% +$8.83M 0.01% 946
2015
Q2
$38.3M Sell
280,016
-54,482
-16% -$7.45M 0.01% 1019
2015
Q1
$41.7M Sell
334,498
-22,419
-6% -$2.79M 0.02% 956
2014
Q4
$32.3M Sell
356,917
-116,677
-25% -$10.5M 0.01% 1123
2014
Q3
$34.2M Buy
473,594
+80,616
+21% +$5.82M 0.01% 1044
2014
Q2
$24.4M Buy
392,978
+40,624
+12% +$2.53M 0.01% 1257
2014
Q1
$24M Sell
352,354
-26,875
-7% -$1.83M 0.01% 1229
2013
Q4
$26.7M Buy
379,229
+41,310
+12% +$2.91M 0.01% 1133
2013
Q3
$24.4M Buy
337,919
+218,397
+183% +$15.8M 0.01% 1077
2013
Q2
$6.66M Buy
+119,522
New +$6.66M ﹤0.01% 2063